scorecardresearch
Wednesday, August 27, 2025
TopicJohnson and Johnson

Topic: Johnson and Johnson

Now, a cancer-causing substance found in Johnson & Johnson’s ‘No More Tears’ baby shampoo 

Two batches of Johnson & Johnson’s popular baby shampoo have been found to be contaminated with formaldehyde.

Shaken by J&J faulty implants, govt to regulate eight more medical devices

According to the Union Health Ministry's internal estimates, over 80 per cent of the Indian medical device market is unregulated.

Supreme Court ends case against US-based pharma J&J for faulty hip implants

The Centre has formulated a scheme to ensure compensation upto Rs 1.22 crore to patients with the faulty hip implants.

J&J says India doesn’t have compensation law, moves Delhi HC against Modi govt

Johnson & Johnson says govt's compensation formula for 'faulty' hip implants is ‘absolutely one-sided’. Centre rushes to Supreme Court.    

Investigation alleges J&J knew its powders have cancer-causing asbestos but hid the info

Reuters investigation report on Johnson & Johnson talc powders was released in the US Friday. J&J has rejected the findings of the report.

Modi govt seals compensation J&J could pay for ‘faulty’ hip implants — Rs 30 lakh minimum

Modi govt frames compensation formula for J&J by tweaking India's clinical trial rules. Now, upper limit is likely to be set at over Rs 1 cr.

Hip implants dent brand Johnson & Johnson, patients begin questioning other devices

Doctors say Johnson & Johnson's hip implant controversy is causing concern among Indian patients fitted with other devices from the company.

On Camera

India will absorb Trump tariff impact due to its Achilles’ heel

Like China, India remains a big domestic market, which will continue to attract investment, but the US tariffs will make India unattractive for future investments.

New insolvency frameworks to shorter timelines, how 2025 amendment bill proposes to transform IBC

New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.

Op Sindoor lesson: IAF chief bats for joint planning & coordination centre in Delhi, not theaterisation

Contrary to claims regarding implementation of theaterisation, ThePrint first reported on 17 June 2021 that it will be delayed. Now, ACM Singh bats for different structure.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.